144 related articles for article (PubMed ID: 36773192)
1. Expansion of large granular lymphocytes after autologous hematopoietic stem cell transplantation.
Yoshida M; Matsuda K; Taoka K; Honda A; Maki H; Masamoto Y; Jona M; Nishikawa M; Yatomi Y; Kurokawa M
Int J Hematol; 2023 Jun; 117(6):839-844. PubMed ID: 36773192
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features and risk factors analyses of patients with T cell large granular lymphocytosis following allo-HSCT].
Zhao F; Shi YY; Zhang GX; Zhai WH; Pang AM; Ma QL; Zhang RL; Wei JL; Huang Y; Yang DL; He Y; Jiang EL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):630-636. PubMed ID: 32942815
[No Abstract] [Full Text] [Related]
3. Large granular lymphocytosis and its impact on long-term clinical outcomes following allo-SCT.
Kim D; Al-Dawsari G; Chang H; Panzarella T; Gupta V; Kuruvilla J; Lipton JH; Messner HA
Bone Marrow Transplant; 2013 Aug; 48(8):1104-11. PubMed ID: 23396405
[TBL] [Abstract][Full Text] [Related]
4. Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data.
Poch Martell M; Hamad N; Shin E; Moon JH; Sohn SK; Uhm J; Michelis FV; Viswabandya A; Lipton JH; Messner HA; Kim DDH
Eur J Haematol; 2017 Aug; 99(2):160-168. PubMed ID: 28449187
[TBL] [Abstract][Full Text] [Related]
5. Large granular lymphocyte expansion after allogeneic hematopoietic stem cell transplant is associated with a cytomegalovirus reactivation and shows an indolent outcome.
Nann-Rütti S; Tzankov A; Cantoni N; Halter J; Heim D; Tsakiris D; Arber C; Buser A; Gratwohl A; Tichelli A; Rovó A
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1765-70. PubMed ID: 22796340
[TBL] [Abstract][Full Text] [Related]
6. Expansion of a clonal CD8+CD57+ large granular lymphocyte population after autologous stem cell transplant in multiple myeloma.
Wolniak KL; Goolsby CL; Chen YH; Chenn A; Singhal S; JayeshMehta ; Peterson LA
Am J Clin Pathol; 2013 Feb; 139(2):231-41. PubMed ID: 23355208
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adults.
Le Bris Y; Guillaume T; Ménard A; Illiaquer M; Martin J; Malard S; Duquesne A; Peterlin P; Debord C; Robillard N; Eveillard M; Wuillème S; Delaunay J; Mohty M; Garnier A; Moreau P; Béné MC; Chevallier P
Bone Marrow Transplant; 2017 Jun; 52(6):854-858. PubMed ID: 28134920
[TBL] [Abstract][Full Text] [Related]
8. Large Granular Lymphocytosis With Cytopenias After Allogeneic Blood or Marrow Transplantation: Clinical Characteristics and Response to Immunosuppressive Therapy.
Messmer M; Wake L; Tsai HL; Jones RJ; Varadhan R; Wagner-Johnston N
Transplant Cell Ther; 2021 Mar; 27(3):260.e1-260.e6. PubMed ID: 33781530
[TBL] [Abstract][Full Text] [Related]
9. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
10. Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.
Krishnan A; Pasquini MC; Logan B; Stadtmauer EA; Vesole DH; Alyea E; Antin JH; Comenzo R; Goodman S; Hari P; Laport G; Qazilbash MH; Rowley S; Sahebi F; Somlo G; Vogl DT; Weisdorf D; Ewell M; Wu J; Geller NL; Horowitz MM; Giralt S; Maloney DG;
Lancet Oncol; 2011 Dec; 12(13):1195-203. PubMed ID: 21962393
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study.
Serio B; Giudice V; Guariglia R; Fontana R; Pezzullo L; Martorelli MC; Ferrara I; Mettivier L; D'Addona M; Vaccaro E; Langella M; Selleri C
Infez Med; 2021 Mar; 29(1):102-113. PubMed ID: 33664179
[TBL] [Abstract][Full Text] [Related]
12. Role of T-cell antigens in the cytolytic activities of large granular lymphocytes (LGLs) in patients with LGL lymphocytosis.
Oshimi K; Oshimi Y; Akahoshi M; Kobayashi Y; Hirai H; Takaku F; Hattori M; Asano S; Kodo H; Nishinarita S
Blood; 1988 Feb; 71(2):473-9. PubMed ID: 2447984
[TBL] [Abstract][Full Text] [Related]
13. A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China.
Gu ZY; Dong YJ; Fu XR; Li NN; Liu Y; Wu XX; Wang YN; Li YH; Ren HY; Zhang MZ; Li XF; Wang MH; Wu YM; Liu DH; Wang Z; Hu LD; Huang WR
Chin Med J (Engl); 2021 Jun; 134(13):1584-1592. PubMed ID: 34133361
[TBL] [Abstract][Full Text] [Related]
14. Indolent T-cell large granular lymphocyte leukaemia after haematopoietic SCT: a clinicopathologic and molecular analysis.
Gill H; Ip AH; Leung R; So JC; Pang AW; Tse E; Leung AY; Lie AK; Kwong YL
Bone Marrow Transplant; 2012 Jul; 47(7):952-6. PubMed ID: 22041849
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
[TBL] [Abstract][Full Text] [Related]
16. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
[TBL] [Abstract][Full Text] [Related]
18. Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients.
Camacho-Bydume C; Mauguen A; Rodriguez-Sanchez MI; Klein E; Kernan NA; Prockop S; Boelens JJ; Papanicolaou GA; Cancio M
Cytotherapy; 2022 Apr; 24(4):428-436. PubMed ID: 35042670
[TBL] [Abstract][Full Text] [Related]
19. Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation.
Makhani SS; Oza SP; Reich-Slotky R; Munshi PN; Biran N; Donato ML; Siegel DS; Vesole DH; Naam S; Rowley SD
Transplant Cell Ther; 2022 Jun; 28(6):306.e1-306.e7. PubMed ID: 35248777
[TBL] [Abstract][Full Text] [Related]
20. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
